Manuel Ibarra

1.7k total citations
58 papers, 968 citations indexed

About

Manuel Ibarra is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Manuel Ibarra has authored 58 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 10 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in Manuel Ibarra's work include Pharmacological Effects and Toxicity Studies (12 papers), Pharmaceutical studies and practices (9 papers) and Epilepsy research and treatment (8 papers). Manuel Ibarra is often cited by papers focused on Pharmacological Effects and Toxicity Studies (12 papers), Pharmaceutical studies and practices (9 papers) and Epilepsy research and treatment (8 papers). Manuel Ibarra collaborates with scholars based in Uruguay, Spain and Argentina. Manuel Ibarra's co-authors include Ángel Cogolludo, Francisco Pérez‐Vizcaíno, Juan Tamargo, Pietro Fagiolino, Marta Vázquez, Juan Duarte, Francisco Zaragozá‐Arnáez, Laura Moreno, Gustavo López‐López and Francisco Javier Ochoa‐Carrillo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Manuel Ibarra

55 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Ibarra Uruguay 15 239 165 133 128 120 58 968
Sümeyya Akyol Türkiye 19 425 1.8× 91 0.6× 174 1.3× 82 0.6× 52 0.4× 65 1.3k
Gary P. Hubbard United Kingdom 11 315 1.3× 423 2.6× 332 2.5× 123 1.0× 31 0.3× 33 1.4k
Alexandra Maier‐Salamon Austria 17 238 1.0× 70 0.4× 84 0.6× 29 0.2× 95 0.8× 31 796
Yüksel Aliyazıcıoğlu Türkiye 22 440 1.8× 248 1.5× 68 0.5× 103 0.8× 68 0.6× 99 1.4k
Amira M. Abo‐Youssef Egypt 20 326 1.4× 68 0.4× 86 0.6× 111 0.9× 34 0.3× 70 1.2k
Gibanananda Ray United States 18 631 2.6× 166 1.0× 108 0.8× 168 1.3× 58 0.5× 21 1.4k
Cristina Nencini Italy 16 364 1.5× 95 0.6× 64 0.5× 41 0.3× 57 0.5× 36 1.3k
Nicole Kerry Australia 9 212 0.9× 227 1.4× 108 0.8× 82 0.6× 52 0.4× 9 829
Lin Huang China 22 460 1.9× 82 0.5× 56 0.4× 58 0.5× 28 0.2× 103 1.3k
Gomaa Mostafa‐Hedeab Egypt 22 431 1.8× 68 0.4× 85 0.6× 129 1.0× 22 0.2× 68 1.3k

Countries citing papers authored by Manuel Ibarra

Since Specialization
Citations

This map shows the geographic impact of Manuel Ibarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Ibarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Ibarra more than expected).

Fields of papers citing papers by Manuel Ibarra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Ibarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Ibarra. The network helps show where Manuel Ibarra may publish in the future.

Co-authorship network of co-authors of Manuel Ibarra

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Ibarra. A scholar is included among the top collaborators of Manuel Ibarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Ibarra. Manuel Ibarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paredes, Alejandro J., et al.. (2025). QbD-based development of extended-release floating furosemide tablets: Formulation and in vitro/in vivo evaluation. Journal of Drug Delivery Science and Technology. 113. 107396–107396.
2.
Ibarra, Manuel, Paulo Cáceres Guidó, Araceli Cresta, et al.. (2025). Population pharmacokinetics of cannabidiol and the impact of food and formulation on systemic exposure in children with drug‐resistant developmental and epileptic encephalopathies. Epilepsia. 66(4). 1143–1154. 1 indexed citations
3.
Monteiro, J. P., R. R. Pinheiro, Vanessa Carla Furtado Mosqueira, et al.. (2025). In vitro infection model in primary macrophages and in vivo evaluation of benzathine cloxacillin nanoparticles for the treatment of Corynebacterium pseudotuberculosis in goats. Small Ruminant Research. 251. 107561–107561.
4.
5.
Michelet, Robin, Jens Markus Borghardt, Teresa Dalla Costa, et al.. (2023). Barriers to global pharmacometrics: educational challenges and opportunities across the globe. CPT Pharmacometrics & Systems Pharmacology. 12(6). 743–747. 7 indexed citations
6.
Maldonado, Cecilia, et al.. (2023). Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation. European Journal of Pharmaceutical Sciences. 183. 106399–106399. 4 indexed citations
7.
8.
Pascual‐Pasto, Guillem, Helena Castillo‐Ecija, Nora Unceta, et al.. (2021). SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas. Journal of Controlled Release. 342. 81–92. 30 indexed citations
9.
Maldonado, Cecilia, et al.. (2020). Pharmacokinetics of Subcutaneous Levetiracetam in Palliative Care Patients. Journal of Palliative Medicine. 24(2). 248–251. 6 indexed citations
10.
Ibarra, Manuel, et al.. (2020). Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies. Cancer Biotherapy and Radiopharmaceuticals. 35(4). 262–270. 22 indexed citations
11.
Fagiolino, Pietro, et al.. (2016). Influence of food and sex on the pharmacokinetics and pharmacodynamics of furosemide.. 20. 45–56. 2 indexed citations
12.
Ibarra, Manuel, et al.. (2016). Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets. European Journal of Pharmaceutical Sciences. 85. 106–111. 10 indexed citations
13.
Ibarra, Manuel, et al.. (2015). A simple pharmacokinetic model based on mean residence times to predict furosemide exposure after oral doses.. International Journal of Pharmacy and Pharmaceutical Sciences. 3(4). 54–65. 2 indexed citations
14.
Fagiolino, Pietro, et al.. (2015). SAFETY ASSESSMENT OF EFAVIRENZ AFTER A SINGLE–DOSE BIOEQUIVALENCE STUDY: A TREND TO CORRELATE CENTRAL NERVOUS SYSTEM EFFECT AND PLASMA CONCENTRATION. International Journal of Pharmacy. 5(15). 46–52. 3 indexed citations
15.
Ibarra, Manuel, et al.. (2015). Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 41(6). 787–793. 14 indexed citations
16.
Pérez‐Vizcaíno, Francisco, Manuel Ibarra, Ángel Cogolludo, et al.. (2002). Endothelium-Independent Vasodilator Effects of the Flavonoid Quercetin and Its Methylated Metabolites in Rat Conductance and Resistance Arteries. Journal of Pharmacology and Experimental Therapeutics. 302(1). 66–72. 167 indexed citations
17.
Ibarra, Manuel, Francisco Pérez‐Vizcaíno, Ángel Cogolludo, et al.. (2002). Cardiovascular Effects of Isorhamnetin and Quercetin in Isolated Rat and Porcine Vascular Smooth Muscle and Isolated Rat Atria. Planta Medica. 68(4). 307–310. 48 indexed citations
18.
Pérez‐Vizcaíno, Francisco, et al.. (2001). Pulmonary Artery Vasoconstriction but not [Ca2+]i Signal Stimulated by Thromboxane A2 Is Partially Resistant to NO. Pediatric Research. 50(4). 508–514. 7 indexed citations
19.
Cogolludo, Ángel, et al.. (1999). Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta. British Journal of Pharmacology. 126(4). 1025–1033. 14 indexed citations
20.
Pérez‐Vizcaíno, Francisco, et al.. (1999). Vasodilator effects of sodium nitroprusside, levcromakalim and their combination in isolated rat aorta. British Journal of Pharmacology. 128(7). 1419–1426. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sümeyya Akyol Breakdown of academic impact, for papers by Gary P. Hubbard Breakdown of academic impact, for papers by Alexandra Maier‐Salamon Breakdown of academic impact, for papers by Yüksel Aliyazıcıoğlu Breakdown of academic impact, for papers by Amira M. Abo‐Youssef Breakdown of academic impact, for papers by Gibanananda Ray Breakdown of academic impact, for papers by Cristina Nencini Breakdown of academic impact, for papers by Nicole Kerry Breakdown of academic impact, for papers by Lin Huang Breakdown of academic impact, for papers by Gomaa Mostafa‐Hedeab
Rankless by CCL
2026